![Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37]](https://cedclinic.com/wp-content/uploads/2026/07/ced-pexels-5021600-150x150.jpg "Cbd Vs Hemp Gummies: Which Is Right For Your Wellness Routine? [Tz8JKLqMk37] 24")
What’s in My Weed?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyCBDTHCHempIndustryDosing Clinical Summary This article examines the results of laboratory testing for…
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyMental HealthAnxietyNeurologyDosingIndustry Why This Matters This Phase 3 trial represents the first…
Ohio Tax Department Amends Adult-Use Cannabis Tax Rules
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearchSafetyHempTHCCBD Why This Matters Ohio’s tax amendments directly affect the cost and…
States Surpass $28 Billion in Tax Revenue From Legal Adult-Use Cannabis Sales
✦ New CED Clinical Relevance #42 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearchSafetyMental HealthAgingHemp Why This Matters Cannabis tax revenue data is clinically relevant…
DEA Begins On-Site Inspections At Marijuana Businesses That Applied For Federal …
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearchCancerSleepTHCSafety Why This Matters Clinicians need to understand that DEA on-site inspections…
What’s in your weed? Study finds issues with labelling, tracking cannabis
✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyIndustryTHCCBDDosing Why This Matters Clinicians need accurate product labeling and composition data…
Only 1 in 3 Older Adults Screened for Cannabis, Drug Use
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. AgingResearchSafetyPolicyMental HealthAnxietyPain Why This Matters Clinicians miss opportunities to identify substance…
Cannabis caution as study finds increased psychosis risk for young people
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. Mental HealthResearchSafetyTHCPediatricsAnxietyNeurology Why This Matters Clinicians treating young patients must weigh…
7 unexpected takeaways from the newest research on cannabis and brain effects
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchMental HealthNeurologyTHCCBDSafetyPolicy Clinical Summary Recent research on cannabis and neurobiological…
One Scientist’s War To Understand Unregulated Drugs
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchHempSafetyPolicyIndustryPainAnxiety Why This Matters Clinicians need standardized cannabis testing data to…